Bristol-Myers says cancer drug met goal in study

Associated Press |

NEW YORK (AP) — Bristol-Myers said Tuesday that its skin cancer drug nivolumab worked in a late-stage clinical trial, leading the drugmaker to end the study early.



Bristol-Myers said patients treated with nivolumab lived longer than patients who received only chemotherapy. The study compared the experimental treatment to an older drug called dacarbazine, and it was designed to evaluate nivolumab as a primary treatment for melanoma, the most dangerous type of skin cancer. Patients in the study had advanced melanoma with a specific genetic mutation.

The company did not report specific results from the trial, which enrolled 418 patients.

Shares of Bristol-Myers Squibb Co. rose $1.15, or 2.4 percent, to $49.45 in aftermarket trading. The stock rose 30 cents to $48.30 during the day.

Nivolumab hasn't yet been approved, but Bristol-Myers Squibb is getting ready to file for approval of the drug as a treatment for non-small cell lung cancer. A drug regimen that combines nivolumab with an approved drug, Yervoy, has also showed promise as a treatment for melanoma.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Companies

Symbol Name Price Change % Volume
ZFPPF Zambeef Product Plc Ord 0.20 0.00 0.00 0

Comments

Emerging Growth

Goldrea Resources Corp.

Goldrea Resources Corp is engaged in the acquisition, exploration and development of mineral properties located in North America.

Private Markets

Quants Inc

Quants, Inc, a California Corporation, develops, markets and operates financial technology platforms and alternative investment products offering sophisticated risk management since 2010. The Company has primarily sharpened its focus with…

Voleo

Voleo is a free download that allows you to form investment clubs with your friends, family, colleagues, classmates, teammates…basically anyone you know and trust. Invest and manage a stock portfolio…